日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis

一项大型多中心分析探讨了直肠癌新辅助治疗后完全缓解的临床和治疗相关预测因素

Wurschi, Georg W; Schneider, Melanie; Becker, Jan-Niklas; Frerker, Bernd; Vorbach, Samuel M; Ehret, Felix; Diefenhardt, Markus; Schunn, Fabian; von Gruben, Maria-Elena; Büttner, Marcel; Hoffmann, Elgin; Rühle, Alexander; Beier, Josephine; Ferdinandus, Simone; Trommer, Maike; Sahin, Ezgi Ceren; Hlouschek, Julian; Aninditha, Kynann; von Ohlen, Daphne Schepers; Kaufmann, Justus; Depardon, Alina; Ha, Hai Minh; Kessler, Christopher; Cieslak, Adrianna; Trommer, Simon; Fabian, Alexander; Sonnhoff, Mathias; Rißner, Florian; Römer, Maximilian; Pietschmann, Klaus

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

托法替尼治疗幼年特发性关节炎:一项3期随机、双盲、安慰剂对照停药试验的患者报告结果

Brunner, Hermine I; Alexeeva, Ekaterina; Bandeira, Marcia; Carrasco, Ruy; Chaitow, Jeffrey; Chiraseveenuprapund, Peter; Ting, Tracy V; Erguven, Muferet; Gottlieb, Beth; Oliveira, Sheila Knupp; Patel, Pooja N; Ozen, Seza; Saad Magalhaes, Claudia; Penadés, Inmaculada Calvo; Gruben, David; Germino, Rebecca; Posner, Holly B; Stockert, Lori; Martini, Alberto; Lovell, Daniel J; Ruperto, Nicolino

Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies

识别接受托法替尼治疗的银屑病关节炎患者的不同疾病活动轨迹:两项 3 期研究的事后分析

Gladman, Dafna; Tillett, William; Gruben, David; Coates, Laura C; Hahne, Stefanie; Volkov, Mikhail

Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials

托法替尼治疗银屑病关节炎合并可能焦虑/抑郁症患者的疗效:3期临床试验的事后分析

Gossec, Laure; Sellas, Agustí; Gruben, David C; Valderrama, Mónica; Gómez, Susana; Kinch, Cassandra; Citera, Gustavo

Characterization of Second-Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry

首次使用JAK抑制剂后二线治疗的特征分析:来自CorEvitas类风湿性关节炎注册研究的结果

Baker, Joshua F; Mizelle, Kristi V; Saikali, Wassim; Moore, Page C; Kang, Hyung-Joo; Gruben, David; Shelbaya, Ahmed; Stockert, Lori; O'Brien, Jacqueline

Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis

针对中重度活动性溃疡性结肠炎,对依曲莫德和奥扎尼莫德的疗效结果进行匹配调整后的间接比较

Jairath, Vipul; Raine, Tim; Leahy, Thomas P; Potluri, Ravi; Wosik, Karolina; Gruben, David; Cappelleri, Joseph C; Hur, Peter; Bartolome, Lauren

Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis

中重度活动性溃疡性结肠炎诱导和维持治疗中先进疗法的疗效和安全性:系统文献综述和贝叶斯网络荟萃分析

Jairath, Vipul; Raine, Tim; Leahy, Thomas P; Potluri, Ravi; Wosik, Karolina; Gruben, David; Cappelleri, Joseph C; Hur, Peter; Bartolome, Lauren

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials

托法替尼治疗类风湿性关节炎患者的疗效、安全性和持续性是否存在性别差异:一项对 III 期临床试验和长期扩展试验的事后分析

Strand, Vibeke; Schulze-Koops, Hendrik; Al-Emadi, Samar; Kinch, Cassandra D; Gruben, David; Germino, Rebecca; Connell, Carol A; Mysler, Eduardo

The FUNG-GROWTH database: linking fungal phenotype to genome

真菌生长数据库:将真菌表型与基因组联系起来

de Vries, Ronald P; Wiebenga, Ad; Aguilar Osorio, Guillermo; Aguilar Pontes, Maria Victoria; Battaglia, Evy; Benocci, Tiziano; Benoit Gelber, Isabelle; Bouzid, Ourdia; Casado Lopez, Sara; Coconi Linares, Nancy; Debets, Alfons J M; de Jong, Jan F J; Drula, Elodie; Falkoski, Daniel; Grijpstra, Jan; Gruben, Birgit S; Klaubauf, Sylvia; Khosravi, Claire; Kowalczyk, Joanna E; Kun, Roland S; Liwanag, April J; Lubbers, Ronnie J M; Majoor, Eline; Misiedjan, Sakinie; Müller, Astrid; Ozturkoglu Budak, Şebnem; Patyshakuliyeva, Aleksandrina; Robl, Diogo; Trejo-Aguilar, Blanca; van den Brink, Joost; Visser, Yoni; Vivas-Duarte, Alexandra; Vugts, Aniek; Zhou, Miaomiao; Peng, Mao; Coutinho, Pedro M; Henrissat, Bernard; Robert, Vincent

Real-world familiarity with US biosimilar regulatory guidelines and interchangeability state laws among pharmacists and physicians treating immunological disorders

药剂师和治疗免疫系统疾病的医生对美国生物类似药监管指南和各州互换性法律的实际了解程度。

Ling, You-Li; Gentile, Danielle; Kotomale, Angele; Sharpe, Jason A; Geli, Danielle; Gruben, David; Omary, Courtney; Brackin, Courtney; Bailey, Mark